Reducing Doxorubicin resistance in breast cancer by liposomal FOXM1 aptamer: In vitro and in vivo
Negin Ghandhariyoun, Mahmoud Reza Jaafari, Sara Nikoofal‐Sahlabadi, Seyed Mohammad Taghdisi, Seyedeh Alia Moosavian
Topics & Concepts
In vivoDoxorubicinAptamerIn vitroBreast cancerLiposomePharmacologyCancer researchChemistryMedicineCancerChemotherapyBiologyInternal medicineBiotechnologyBiochemistryMolecular biologyFOXO transcription factor regulationCancer Cells and MetastasisCancer Mechanisms and Therapy